{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:00:44Z","timestamp":1790838044918,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.biopha.2025.118124","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T23:48:37Z","timestamp":1746229717000},"page":"118124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Levosimendan mitigates renal fibrosis via TGF-\u03b21\/Smad axis modulation in UUO rats"],"prefix":"10.1016","volume":"187","author":[{"given":"Rohan","family":"Bhadange","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Dagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil Bhanudas","family":"Gaikwad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10302","key":"10.1016\/j.biopha.2025.118124_bib1","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0140-6736(21)00519-5","article-title":"Chronic kidney disease","volume":"398","author":"Kalantar-Zadeh","year":"2021","journal-title":"lancet"},{"issue":"1","key":"10.1016\/j.biopha.2025.118124_bib2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s12325-021-01927-z","article-title":"A narrative review of chronic kidney disease in clinical practice: current challenges and future perspectives","volume":"39","author":"Evans","year":"2022","journal-title":"Adv. Ther."},{"issue":"10","key":"10.1016\/j.biopha.2025.118124_bib3","doi-asserted-by":"crossref","first-page":"4405","DOI":"10.1007\/s12325-023-02608-9","article-title":"Global economic burden associated with chronic kidney disease: a pragmatic review of medical costs for the Inside CKD Research Programme","volume":"40","author":"Jha","year":"2023","journal-title":"Adv. Ther."},{"key":"10.1016\/j.biopha.2025.118124_bib4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejphar.2017.12.016","article-title":"Inflammation and renal fibrosis: recent developments on key signaling molecules as potential therapeutic targets","volume":"820","author":"Lv","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2025.118124_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.628519","article-title":"TGF-\u03b21 signaling: immune dynamics of chronic kidney diseases","volume":"8","author":"Tang","year":"2021","journal-title":"Front. Med."},{"issue":"4","key":"10.1016\/j.biopha.2025.118124_bib6","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3390\/biom9040141","article-title":"Unilateral ureteral obstruction as a model to investigate fibrosis-attenuating treatments","volume":"9","author":"Mart\u00ednez-Klimova","year":"2019","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.biopha.2025.118124_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148542","article-title":"Mesenchymal stromal cells prevent renal fibrosis in a rat model of unilateral ureteral obstruction by suppressing the renin-angiotensin system via HuR","volume":"11","author":"Gregorini","year":"2016","journal-title":"PLOS One"},{"key":"10.1016\/j.biopha.2025.118124_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119241","article-title":"Nifuroxazide suppresses UUO-induced renal fibrosis in rats via inhibiting STAT-3\/NF-\u03baB signaling, oxidative stress and inflammation","volume":"272","author":"Hassan","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2025.118124_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120527","article-title":"Biochanin A alleviates unilateral ureteral obstruction-induced renal interstitial fibrosis and inflammation by inhibiting the TGF-\u03b21\/Smad2\/3 and NF-kB\/NLRP3 signaling axis in mice","volume":"298","author":"Ram","year":"2022","journal-title":"Life Sci."},{"issue":"10","key":"10.1016\/j.biopha.2025.118124_bib10","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.34067\/KID.0000000000000227","article-title":"Animal models of kidney disease: challenges and perspectives","volume":"4","author":"Liang","year":"2023","journal-title":"Kidney360"},{"key":"10.1016\/j.biopha.2025.118124_bib11","doi-asserted-by":"crossref","unstructured":"T. Tarun, Updates on new therapies for patients with CKD. Kidney International Reports, 2023..","DOI":"10.1016\/j.ekir.2023.10.006"},{"key":"10.1016\/j.biopha.2025.118124_bib12","doi-asserted-by":"crossref","DOI":"10.1177\/2515690X221079688","article-title":"Promoting plant-based therapies for chronic kidney disease","volume":"27","author":"Khan","year":"2022","journal-title":"J. Evid. -Based Integr. Med."},{"issue":"2","key":"10.1016\/j.biopha.2025.118124_bib13","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1517\/14728214.2014.900044","article-title":"Emerging drugs for chronic kidney disease","volume":"19","author":"Stefoni","year":"2014","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.biopha.2025.118124_bib14","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1208\/s12248-012-9390-1","article-title":"Drug repurposing: far beyond new targets for old drugs","volume":"14","author":"Oprea","year":"2012","journal-title":"AAPS J."},{"key":"10.1016\/j.biopha.2025.118124_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.172960","article-title":"Effect of levosimendan, an inodilator, on streptozotocin-induced diabetic nephropathy in rats","volume":"873","author":"Abdelrahman","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118124_bib16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/ejhf.9","article-title":"Levosimendan improves renal function in acute decompensated heart failure: possible underlying mechanisms","volume":"16","author":"Fedele","year":"2014","journal-title":"Eur. J. Heart Fail."},{"issue":"5","key":"10.1016\/j.biopha.2025.118124_bib17","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1053\/j.jvca.2018.02.039","article-title":"Effect of levosimendan on renal outcome in cardiac surgery patients with chronic kidney disease and perioperative cardiovascular dysfunction: a substudy of a multicenter randomized trial","volume":"32","author":"Zangrillo","year":"2018","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"10.1016\/j.biopha.2025.118124_bib18","first-page":"rgaf002","article-title":"Repurposing the familiar: future treatment options against chronic kidney disease","author":"Bhadange","year":"2025","journal-title":"J. Pharm. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118124_bib19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s13054-021-03628-z","article-title":"Effects of levosimendan on renal blood flow and glomerular filtration in patients with acute kidney injury after cardiac surgery: a double blind, randomized placebo-controlled study","volume":"25","author":"Thol\u00e9n","year":"2021","journal-title":"Crit. Care"},{"key":"10.1016\/j.biopha.2025.118124_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112931","article-title":"Losartan ameliorates renal interstitial fibrosis through metabolic pathway and Smurfs-TGF-\u03b2\/Smad","volume":"149","author":"Zou","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2025.118124_bib21","doi-asserted-by":"crossref","first-page":"1456721","DOI":"10.3389\/fphar.2024.1456721","article-title":"Spatiotemporal delivery of multiple components of rhubarb-astragalus formula for the sysnergistic treatment of renal fibrosis","volume":"15","author":"Zhang","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2025.118124_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112745","article-title":"Combined levosimendan and sacubitril\/valsartan markedly protected the heart and kidney against cardiorenal syndrome in rat","volume":"148","author":"Sung","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.biopha.2025.118124_bib23","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/10715762.2024.2313738","article-title":"Renoprotective effect of esculetin against ischemic acute kidney injury-diabetic comorbidity","volume":"58","author":"Dagar","year":"2024","journal-title":"Free Radic. Res."},{"issue":"3","key":"10.1016\/j.biopha.2025.118124_bib24","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/cvr\/cvz163","article-title":"Levosimendan prevents doxorubicin-induced cardiotoxicity in time-and dose-dependent manner: implications for inotropy","volume":"116","author":"Efentakis","year":"2020","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.biopha.2025.118124_bib25","first-page":"115","article-title":"Neuroprotective effects of levosimendan on the nb2a mouse neuroblastoma cell culture","volume":"26","author":"\u00d6zt\u00fcrk","year":"2020","journal-title":"J. Cardio-Vasc. -Thorac. Anaesth. Intensive Care Soc."},{"issue":"1","key":"10.1016\/j.biopha.2025.118124_bib26","doi-asserted-by":"crossref","first-page":"8593617","DOI":"10.1155\/2020\/8593617","article-title":"Levosimendan protects against doxorubicin-induced cardiotoxicity by regulating the PTEN\/Akt pathway","volume":"2020","author":"Li","year":"2020","journal-title":"BioMed. Res. Int."},{"issue":"12","key":"10.1016\/j.biopha.2025.118124_bib27","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.3390\/cells12121581","article-title":"The role of inflammation in CKD","volume":"12","author":"Kadatane","year":"2023","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.biopha.2025.118124_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/mmr.2024.13267","article-title":"TGF\u2011\u03b2\/Smad signaling in chronic kidney disease: exploring post\u2011translational regulatory perspectives","volume":"30","author":"Li","year":"2024","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.biopha.2025.118124_bib29","article-title":"TGF-\u03b2\/Smad signaling pathway in tubulointerstitial fibrosis","volume":"13","author":"Yu","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"12","key":"10.1016\/j.biopha.2025.118124_bib30","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.3390\/ph15121485","article-title":"TGF-\u03b2 inhibitors for therapeutic management of kidney fibrosis","volume":"15","author":"Park","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.biopha.2025.118124_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103942","article-title":"Hypoxia and chronic kidney disease","volume":"77","author":"Wang","year":"2022","journal-title":"EBioMedicine"},{"issue":"4","key":"10.1016\/j.biopha.2025.118124_bib32","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/ejhf.2814","article-title":"Inotropic therapy in patients with advanced heart failure. A clinical consensus statement from the heart failure association of the european society of cardiology","volume":"25","author":"Gustafsson","year":"2023","journal-title":"Eur. J. Heart Fail."},{"issue":"2","key":"10.1016\/j.biopha.2025.118124_bib33","doi-asserted-by":"crossref","first-page":"136","DOI":"10.4097\/kjae.2014.66.2.136","article-title":"Effect of milrinone on the inflammatory response and NF-kB activation in renal ischemia-reperfusion injury in mice","volume":"66","author":"Jung","year":"2014","journal-title":"Korean J. Anesthesiol."},{"key":"10.1016\/j.biopha.2025.118124_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.etap.2021.103625","article-title":"Dasatinib mitigates renal fibrosis in a rat model of UUO via inhibition of Src\/STAT-3\/NF-\u03baB signaling","volume":"84","author":"Hassan","year":"2021","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.biopha.2025.118124_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115098","article-title":"Discovery of a chalcone derivative as an anti-fibrotic agent targeting transforming growth factor-\u03b21 signaling: potential therapy of renal fibrosis","volume":"165","author":"Poolsri","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2025.118124_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106249","article-title":"Hirudin improves renal interstitial fibrosis by reducing renal tubule injury and inflammation in unilateral ureteral obstruction (UUO) mice","volume":"81","author":"Xie","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118124_bib37","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1152\/physrev.00027.2022","article-title":"Obstructive nephropathy and molecular pathophysiology of renal interstitial fibrosis","volume":"103","author":"N\u00f8rregaard","year":"2023","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2025.118124_bib38","first-page":"95","article-title":"Inhibition of histone deacetylase 1 ameliorates renal tubulointerstitial fibrosis via modulation of inflammation and extracellular matrix gene transcription in mice","volume":"41","author":"Nguy\u1ec5n-Thanh","year":"2018","journal-title":"Int. J. Mol. Med."},{"issue":"23","key":"10.1016\/j.biopha.2025.118124_bib39","doi-asserted-by":"crossref","first-page":"8687","DOI":"10.1073\/pnas.0400035101","article-title":"Down-regulation of Smad7 expression by ubiquitin-dependent degradation contributes to renal fibrosis in obstructive nephropathy in mice","volume":"101","author":"Fukasawa","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.biopha.2025.118124_bib40","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4103\/tcmj.tcmj_106_23","article-title":"Ellagic acid ameliorates renal fibrogenesis by blocking epithelial-to-mesenchymal transition","volume":"36","author":"Huang","year":"2024","journal-title":"Tzu Chi Med. J."},{"key":"10.1016\/j.biopha.2025.118124_bib41","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.bbrc.2022.03.097","article-title":"CUX1 promotes epithelial-mesenchymal transition (EMT) in renal fibrosis of UUO model by targeting MMP7","volume":"608","author":"Teng","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2025.118124_bib42","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fcell.2020.00123","article-title":"Diverse role of TGF-\u03b2 in kidney disease","volume":"8","author":"Gu","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118124_bib43","doi-asserted-by":"crossref","first-page":"194","DOI":"10.7150\/ijbs.39024","article-title":"Ruxolitinib alleviates renal interstitial fibrosis in UUO mice","volume":"16","author":"Bai","year":"2020","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118124_bib44","doi-asserted-by":"crossref","first-page":"2085303","DOI":"10.1155\/2020\/2085303","article-title":"Oleanolic acid attenuates renal fibrosis through tgf-\u03b2\/smad pathway in a rat model of unilateral ureteral obstruction","volume":"2020","author":"Zhao","year":"2020","journal-title":"Evid. -Based Complement. Altern. Med."},{"key":"10.1016\/j.biopha.2025.118124_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.830340","article-title":"Emerging therapeutic strategies for attenuating tubular EMT and kidney fibrosis by targeting Wnt\/\u03b2-catenin signaling","volume":"12","author":"Hu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2025.118124_bib46","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1007\/s00204-020-02829-9","article-title":"Ochratoxin A induces epithelial-to-mesenchymal transition and renal fibrosis through TGF-\u03b2\/Smad2\/3 and Wnt1\/\u03b2-catenin signaling pathways in vitro and in vivo","volume":"94","author":"Pyo","year":"2020","journal-title":"Arch. Toxicol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118124_bib47","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.kint.2019.08.028","article-title":"The deacetylase sirtuin 6 protects against kidney fibrosis by epigenetically blocking \u03b2-catenin target gene expression","volume":"97","author":"Cai","year":"2020","journal-title":"Kidney Int."},{"issue":"24","key":"10.1016\/j.biopha.2025.118124_bib48","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.122399","article-title":"Tubular injury triggers podocyte dysfunction by \u03b2-catenin\u2013driven release of MMP-7","volume":"4","author":"Tan","year":"2019","journal-title":"JCI Insight"},{"issue":"10","key":"10.1016\/j.biopha.2025.118124_bib49","doi-asserted-by":"crossref","first-page":"7026","DOI":"10.1074\/jbc.M111.276311","article-title":"Interactions between \u03b2-catenin and transforming growth factor-\u03b2 signaling pathways mediate epithelial-mesenchymal transition and are dependent on the transcriptional co-activator cAMP-response element-binding protein (CREB)-binding protein (CBP)","volume":"287","author":"Zhou","year":"2012","journal-title":"J. Biol. Chem."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222500318X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222500318X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T19:51:29Z","timestamp":1759002689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222500318X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":49,"alternative-id":["S075333222500318X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118124","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Levosimendan mitigates renal fibrosis via TGF-\u03b21\/Smad axis modulation in UUO rats","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118124","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118124"}}